Bank of New York Mellon Corp - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$63,287,496
+0.3%
621,319
-0.6%
0.01%
+7.7%
Q2 2023$63,084,405
+9.7%
625,155
-0.0%
0.01%0.0%
Q1 2023$57,522,801
-8.1%
625,248
-9.4%
0.01%
-7.1%
Q4 2022$62,616,327
+23.6%
690,215
+3.6%
0.01%
+16.7%
Q3 2022$50,656,000
-21.6%
666,443
-12.8%
0.01%
-20.0%
Q2 2022$64,640,000
-5.0%
764,684
-1.4%
0.02%
+15.4%
Q1 2022$68,076,000
+5.1%
775,789
+4.8%
0.01%
+8.3%
Q4 2021$64,763,000
+14.9%
740,419
+7.5%
0.01%
+9.1%
Q3 2021$56,352,000
-4.4%
689,059
+6.6%
0.01%0.0%
Q2 2021$58,965,000
+10.6%
646,264
+3.6%
0.01%0.0%
Q1 2021$53,311,000
-8.3%
623,676
+1.3%
0.01%
-15.4%
Q4 2020$58,133,000
+5.7%
615,622
-2.7%
0.01%
-7.1%
Q3 2020$55,007,000
-2.8%
632,546
-2.4%
0.01%
-6.7%
Q2 2020$56,603,000
-5.6%
648,082
-10.9%
0.02%
-25.0%
Q1 2020$59,978,000
-16.8%
727,448
-4.4%
0.02%
+5.3%
Q4 2019$72,071,000
+32.3%
761,119
+21.4%
0.02%
+26.7%
Q3 2019$54,485,000
-1.7%
626,975
+3.3%
0.02%0.0%
Q2 2019$55,415,000
-4.3%
606,874
+0.7%
0.02%
-6.2%
Q1 2019$57,926,000
+5.3%
602,504
-6.0%
0.02%
-5.9%
Q4 2018$54,990,000
+0.4%
640,815
+0.8%
0.02%
+21.4%
Q3 2018$54,780,000
+5.7%
635,797
-7.4%
0.01%0.0%
Q2 2018$51,838,000
-36.0%
686,237
-31.5%
0.01%
-36.4%
Q1 2018$80,938,000
-7.5%
1,001,079
-3.9%
0.02%
-4.3%
Q4 2017$87,491,000
-2.2%
1,042,080
-0.0%
0.02%
-8.0%
Q3 2017$89,474,000
+2.6%
1,042,209
-0.3%
0.02%0.0%
Q2 2017$87,223,000
+8.9%
1,044,975
-3.1%
0.02%
+13.6%
Q1 2017$80,074,000
-3.8%
1,078,112
-5.7%
0.02%
-8.3%
Q4 2016$83,261,000
-9.3%
1,143,055
-1.7%
0.02%
-11.1%
Q3 2016$91,842,000
-8.3%
1,163,143
-4.2%
0.03%
-12.9%
Q2 2016$100,168,000
+14.0%
1,214,011
+0.1%
0.03%
+14.8%
Q1 2016$87,896,000
-18.1%
1,213,360
-2.7%
0.03%
-15.6%
Q4 2015$107,300,000
-8.7%
1,247,101
-2.5%
0.03%
-11.1%
Q3 2015$117,544,000
-21.3%
1,278,761
-15.8%
0.04%
-12.2%
Q2 2015$149,355,000
-7.6%
1,518,767
-7.4%
0.04%
-2.4%
Q1 2015$161,719,000
-10.4%
1,640,000
-15.8%
0.04%
-10.6%
Q4 2014$180,542,000
+52.3%
1,948,443
+54.7%
0.05%
+46.9%
Q3 2014$118,570,000
-48.7%
1,259,626
-50.7%
0.03%
+3.2%
Q2 2014$231,268,000
+79.8%
2,554,634
+68.9%
0.03%
-11.4%
Q1 2014$128,608,000
+21.0%
1,512,679
+14.4%
0.04%
+16.7%
Q4 2013$106,273,000
-49.2%
1,322,118
-51.6%
0.03%
-3.2%
Q3 2013$209,396,000
+183.4%
2,729,686
+161.2%
0.03%
+34.8%
Q2 2013$73,892,0001,045,0050.02%
Other shareholders
NOVARTIS A G shareholders Q2 2021
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders